Combination of somatostatin analogues and dexamethasone (antisurvival‐factor concept) with luteinizing hormone‐releasing hormone in androgen ablation‐refractory prostate cancer with bone metastasis
Gespeichert in:
| Veröffentlicht in: | BJU international 2007-07, Vol.100 (s2), p.60-62 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 62 |
|---|---|
| container_issue | s2 |
| container_start_page | 60 |
| container_title | BJU international |
| container_volume | 100 |
| creator | Koutsilieris, Michael Dimopoulos, Theodore Milathianakis, Constantine Bogdanos, John Karamanolakis, Dimitrios Pissimissis, Nicholas Halapas, Antonis Lembessis, Peter Papaioannou, Andreas Sourla, Antigone |
| description | |
| doi_str_mv | 10.1111/j.1464-410X.2007.06958.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70657580</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70657580</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4178-3a608886c7e021b8ca946c0401ebe1bf67a2e11a6e82416973509f81a4a885af3</originalsourceid><addsrcrecordid>eNqNUcFu1DAQjRCIlsIvIJ8QHDa1N4njHDjAigJVpV6oxM2aeCe7Xjn2YjvtLqd-Av_FX_AlONmFcsQXP828efPsl2WE0Zylc77JWcnLWcno13xOaZ1T3lQi3z3KTv82Hv_BtOEn2bMQNpSmAq-eZiesrpqy4MVp9nPh-lZbiNpZ4joSXA_RhZgKloAF41YDhoSWZIk76DGuITiL5DXYqMPgb_UtmF_3PzpQ0XminFW4jW_InY5rYoaI2urv2q7I2vk-DSaqR4MQ_qmRadfSuxUm0JrJzUTs_CS7J1s_mUKiIC3wB_l2nE2WILWCDs-zJx2YgC-O91l2c_Hhy-LT7Or64-fFu6uZKlktZgVwKoTgqkY6Z61Q0JRc0ZIybJG1Ha9hjowBRzEvGW_qoqJNJxiUIEQFXXGWvTroJlPf0u9E2eug0Biw6IYga8qruhI0EcWBqJL7kF4jt1734PeSUTkGKTdyzEiOeckxSDkFKXdp9OVxx9D2uHwYPCaXCG8PhDttcP_fwvL95c2Iit-UqLcB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70657580</pqid></control><display><type>article</type><title>Combination of somatostatin analogues and dexamethasone (antisurvival‐factor concept) with luteinizing hormone‐releasing hormone in androgen ablation‐refractory prostate cancer with bone metastasis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Koutsilieris, Michael ; Dimopoulos, Theodore ; Milathianakis, Constantine ; Bogdanos, John ; Karamanolakis, Dimitrios ; Pissimissis, Nicholas ; Halapas, Antonis ; Lembessis, Peter ; Papaioannou, Andreas ; Sourla, Antigone</creator><creatorcontrib>Koutsilieris, Michael ; Dimopoulos, Theodore ; Milathianakis, Constantine ; Bogdanos, John ; Karamanolakis, Dimitrios ; Pissimissis, Nicholas ; Halapas, Antonis ; Lembessis, Peter ; Papaioannou, Andreas ; Sourla, Antigone</creatorcontrib><identifier>ISSN: 1464-4096</identifier><identifier>EISSN: 1464-410X</identifier><identifier>DOI: 10.1111/j.1464-410X.2007.06958.x</identifier><identifier>PMID: 17594363</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Androgen Antagonists - therapeutic use ; Antineoplastic Agents, Hormonal - therapeutic use ; Bone Neoplasms - drug therapy ; Bone Neoplasms - secondary ; Dexamethasone - therapeutic use ; Gonadotropin-Releasing Hormone - antagonists & inhibitors ; Humans ; Male ; Prostatic Neoplasms - drug therapy ; Somatostatin - analogs & derivatives</subject><ispartof>BJU international, 2007-07, Vol.100 (s2), p.60-62</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4178-3a608886c7e021b8ca946c0401ebe1bf67a2e11a6e82416973509f81a4a885af3</citedby><cites>FETCH-LOGICAL-c4178-3a608886c7e021b8ca946c0401ebe1bf67a2e11a6e82416973509f81a4a885af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1464-410X.2007.06958.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1464-410X.2007.06958.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17594363$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koutsilieris, Michael</creatorcontrib><creatorcontrib>Dimopoulos, Theodore</creatorcontrib><creatorcontrib>Milathianakis, Constantine</creatorcontrib><creatorcontrib>Bogdanos, John</creatorcontrib><creatorcontrib>Karamanolakis, Dimitrios</creatorcontrib><creatorcontrib>Pissimissis, Nicholas</creatorcontrib><creatorcontrib>Halapas, Antonis</creatorcontrib><creatorcontrib>Lembessis, Peter</creatorcontrib><creatorcontrib>Papaioannou, Andreas</creatorcontrib><creatorcontrib>Sourla, Antigone</creatorcontrib><title>Combination of somatostatin analogues and dexamethasone (antisurvival‐factor concept) with luteinizing hormone‐releasing hormone in androgen ablation‐refractory prostate cancer with bone metastasis</title><title>BJU international</title><addtitle>BJU Int</addtitle><subject>Androgen Antagonists - therapeutic use</subject><subject>Antineoplastic Agents, Hormonal - therapeutic use</subject><subject>Bone Neoplasms - drug therapy</subject><subject>Bone Neoplasms - secondary</subject><subject>Dexamethasone - therapeutic use</subject><subject>Gonadotropin-Releasing Hormone - antagonists & inhibitors</subject><subject>Humans</subject><subject>Male</subject><subject>Prostatic Neoplasms - drug therapy</subject><subject>Somatostatin - analogs & derivatives</subject><issn>1464-4096</issn><issn>1464-410X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUcFu1DAQjRCIlsIvIJ8QHDa1N4njHDjAigJVpV6oxM2aeCe7Xjn2YjvtLqd-Av_FX_AlONmFcsQXP828efPsl2WE0Zylc77JWcnLWcno13xOaZ1T3lQi3z3KTv82Hv_BtOEn2bMQNpSmAq-eZiesrpqy4MVp9nPh-lZbiNpZ4joSXA_RhZgKloAF41YDhoSWZIk76DGuITiL5DXYqMPgb_UtmF_3PzpQ0XminFW4jW_InY5rYoaI2urv2q7I2vk-DSaqR4MQ_qmRadfSuxUm0JrJzUTs_CS7J1s_mUKiIC3wB_l2nE2WILWCDs-zJx2YgC-O91l2c_Hhy-LT7Or64-fFu6uZKlktZgVwKoTgqkY6Z61Q0JRc0ZIybJG1Ha9hjowBRzEvGW_qoqJNJxiUIEQFXXGWvTroJlPf0u9E2eug0Biw6IYga8qruhI0EcWBqJL7kF4jt1734PeSUTkGKTdyzEiOeckxSDkFKXdp9OVxx9D2uHwYPCaXCG8PhDttcP_fwvL95c2Iit-UqLcB</recordid><startdate>200707</startdate><enddate>200707</enddate><creator>Koutsilieris, Michael</creator><creator>Dimopoulos, Theodore</creator><creator>Milathianakis, Constantine</creator><creator>Bogdanos, John</creator><creator>Karamanolakis, Dimitrios</creator><creator>Pissimissis, Nicholas</creator><creator>Halapas, Antonis</creator><creator>Lembessis, Peter</creator><creator>Papaioannou, Andreas</creator><creator>Sourla, Antigone</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200707</creationdate><title>Combination of somatostatin analogues and dexamethasone (antisurvival‐factor concept) with luteinizing hormone‐releasing hormone in androgen ablation‐refractory prostate cancer with bone metastasis</title><author>Koutsilieris, Michael ; Dimopoulos, Theodore ; Milathianakis, Constantine ; Bogdanos, John ; Karamanolakis, Dimitrios ; Pissimissis, Nicholas ; Halapas, Antonis ; Lembessis, Peter ; Papaioannou, Andreas ; Sourla, Antigone</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4178-3a608886c7e021b8ca946c0401ebe1bf67a2e11a6e82416973509f81a4a885af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Androgen Antagonists - therapeutic use</topic><topic>Antineoplastic Agents, Hormonal - therapeutic use</topic><topic>Bone Neoplasms - drug therapy</topic><topic>Bone Neoplasms - secondary</topic><topic>Dexamethasone - therapeutic use</topic><topic>Gonadotropin-Releasing Hormone - antagonists & inhibitors</topic><topic>Humans</topic><topic>Male</topic><topic>Prostatic Neoplasms - drug therapy</topic><topic>Somatostatin - analogs & derivatives</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koutsilieris, Michael</creatorcontrib><creatorcontrib>Dimopoulos, Theodore</creatorcontrib><creatorcontrib>Milathianakis, Constantine</creatorcontrib><creatorcontrib>Bogdanos, John</creatorcontrib><creatorcontrib>Karamanolakis, Dimitrios</creatorcontrib><creatorcontrib>Pissimissis, Nicholas</creatorcontrib><creatorcontrib>Halapas, Antonis</creatorcontrib><creatorcontrib>Lembessis, Peter</creatorcontrib><creatorcontrib>Papaioannou, Andreas</creatorcontrib><creatorcontrib>Sourla, Antigone</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>BJU international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koutsilieris, Michael</au><au>Dimopoulos, Theodore</au><au>Milathianakis, Constantine</au><au>Bogdanos, John</au><au>Karamanolakis, Dimitrios</au><au>Pissimissis, Nicholas</au><au>Halapas, Antonis</au><au>Lembessis, Peter</au><au>Papaioannou, Andreas</au><au>Sourla, Antigone</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combination of somatostatin analogues and dexamethasone (antisurvival‐factor concept) with luteinizing hormone‐releasing hormone in androgen ablation‐refractory prostate cancer with bone metastasis</atitle><jtitle>BJU international</jtitle><addtitle>BJU Int</addtitle><date>2007-07</date><risdate>2007</risdate><volume>100</volume><issue>s2</issue><spage>60</spage><epage>62</epage><pages>60-62</pages><issn>1464-4096</issn><eissn>1464-410X</eissn><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17594363</pmid><doi>10.1111/j.1464-410X.2007.06958.x</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1464-4096 |
| ispartof | BJU international, 2007-07, Vol.100 (s2), p.60-62 |
| issn | 1464-4096 1464-410X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70657580 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Androgen Antagonists - therapeutic use Antineoplastic Agents, Hormonal - therapeutic use Bone Neoplasms - drug therapy Bone Neoplasms - secondary Dexamethasone - therapeutic use Gonadotropin-Releasing Hormone - antagonists & inhibitors Humans Male Prostatic Neoplasms - drug therapy Somatostatin - analogs & derivatives |
| title | Combination of somatostatin analogues and dexamethasone (antisurvival‐factor concept) with luteinizing hormone‐releasing hormone in androgen ablation‐refractory prostate cancer with bone metastasis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T18%3A18%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combination%20of%20somatostatin%20analogues%20and%20dexamethasone%20(antisurvival%E2%80%90factor%20concept)%20with%20luteinizing%20hormone%E2%80%90releasing%20hormone%20in%20androgen%20ablation%E2%80%90refractory%20prostate%20cancer%20with%20bone%20metastasis&rft.jtitle=BJU%20international&rft.au=Koutsilieris,%20Michael&rft.date=2007-07&rft.volume=100&rft.issue=s2&rft.spage=60&rft.epage=62&rft.pages=60-62&rft.issn=1464-4096&rft.eissn=1464-410X&rft_id=info:doi/10.1111/j.1464-410X.2007.06958.x&rft_dat=%3Cproquest_cross%3E70657580%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70657580&rft_id=info:pmid/17594363&rfr_iscdi=true |